{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:03:20Z","timestamp":1772805800444,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":5029,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1046\/j.1523-1755.2002.00214.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T09:47:55Z","timestamp":1047462475000},"page":"1098-1114","source":"Crossref","is-referenced-by-count":160,"title":["Mycophenolate mofetil treatment for primary glomerular diseases"],"prefix":"10.1016","volume":"61","author":[{"given":"Michael J.","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph A.","family":"Eustace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis F.","family":"Gimenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed G.","family":"Atta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Scheel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renuka","family":"Sothinathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1053\/ajkd.1998.v31.pm9469489","article-title":"Successful mycophenolate mofetil treatment of glomerular disease","volume":"31","author":"Briggs","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0015","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1681\/ASN.V104833","article-title":"Mycophenolate mofetil therapy in lupus nephritis: Clinical observations","volume":"10","author":"Dooley","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0020","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1053\/ajkd.1998.v32.pm9708620","article-title":"Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide","volume":"32","author":"Glicklich","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0025","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM200010193431604","article-title":"Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis","volume":"343","author":"Chan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0030","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1046\/j.1523-1755.1998.00138.x","article-title":"Mycophenolate mofetil attenuates renal injury in the rat remnant kidney","volume":"54","author":"Fujihara","year":"1998","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0035","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1046\/j.1523-1755.1999.055003945.x","article-title":"Mycophenolate mofetil prevents the progressive renal failure induced by 5\/6 renal ablation in rats","volume":"55","author":"Romero","year":"1999","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0040","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1681\/ASN.V1071542","article-title":"Combining an antiproteinuric approach with mycophenolate mofetil fully suppresses progressive nephropathy of experimental animals","volume":"10","author":"Remuzzi","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0045","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1681\/ASN.V112283","article-title":"Combined mycophenolate mofetil and losartan therapy arrests established injury in the remnant kidney","volume":"11","author":"Fujihara","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1523-1755.2000.00140.x","article-title":"Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney","volume":"58","author":"Badid","year":"2000","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0055","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1681\/ASN.V9122272","article-title":"Mycophenolate mofetil prevents the induction of active Heymann nephritis: Association with Th2 cytokine inhibition","volume":"9","author":"Penny","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0060","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/ndt\/14.1.58","article-title":"Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion","volume":"14","author":"Hauser","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0065","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1681\/ASN.V9112055","article-title":"Mycophenolic acid: A new approach to the therapy of experimental mesangial proliferative glomerulonephritis","volume":"9","author":"Ziswiler","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0070","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/ki.1997.217","article-title":"Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease","volume":"51","author":"Corna","year":"1997","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0075","first-page":"2364","article-title":"Mycophenolate mofetil suppresses autoimmunity and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus","volume":"25","author":"McMurray","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0080","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.V981407","article-title":"Attenuation of murine lupus nephritis by mycophenolate mofetil","volume":"9","author":"Van Bruggen","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0085","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0140-6736(05)60198-5","article-title":"Mycophenolate mofetil for systemic vasculitis and IgA nephropathy (letter)","volume":"349","author":"Nowack","year":"1997","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0090","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s004670050047","article-title":"Remission of relapsing childhood nephrotic syndrome with mycophenolate mofetil","volume":"14","author":"Chandra","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0095","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/ajkd.2000.8968","article-title":"Use of mycophenolate mofetil in resistant membranous nephropathy","volume":"36","author":"Miller","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0100","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1681\/ASN.V1091965","article-title":"Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: A pilot study of 11 patients with renal involvement","volume":"10","author":"Nowack","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0105","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"For the Modification of Diet in Renal Disease Study Group: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-3083.1991.tb03746.x","article-title":"Lymphocyte selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: Role of deoxyguanosine nucleotide depletion","volume":"33","author":"Eugui","year":"1991","journal-title":"Scand J Immunol"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0955-470X(05)80012-6","article-title":"Mycophenolate mofetil (RS-61443): Mechanism of action and effects in transplantation","volume":"7","author":"Allison","year":"1993","journal-title":"Transplant Rev"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0120","first-page":"3205","article-title":"Preferential suppression of lymphocyte proliferation by mycophenolic acid and predicted long-term effects of mycophenolate mofetil in transplantation","volume":"26","author":"Allison","year":"1994","journal-title":"Transplant Proc"},{"issue":"Suppl 2","key":"10.1046\/j.1523-1755.2002.00214.x_bb0125","first-page":"67","article-title":"Mycophenolic acid and brequinar, inhibitors of purine and pyrimidine synthesis, block the glycosylation of adhesion molecules","volume":"25","author":"Allison","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0130","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1749-6632.1993.tb17146.x","article-title":"Brequinar sodium, mycophenolic acid, and cyclosporin A inhibit different stages of IL-4- or IL-13-induced human IgG4 and IgE production in vitro","volume":"696","author":"Chang","year":"1993","journal-title":"Ann NY Acac Sci"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0135","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0041-1345(98)01984-8","article-title":"Mycophenolate mofetil impairs transendothelial migration of allogeneic CD4 and CD8 T-cells","volume":"31","author":"Blaheta","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0140","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/00007890-199511270-00015","article-title":"Mycophenolic acid, an inhibitor of IMP dehydrogenase that is also an immunosuppressive agent, suppresses the cytokine-induced nitric oxide production in mouse and rat vascular endothelial cells","volume":"60","author":"Senda","year":"1995","journal-title":"Transplantation"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0145","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00007890-199908150-00014","article-title":"Mycophenolic acid increases apoptosis in lysosomes and lipid droplets in human lymphoid and monocytic cell lines","volume":"68","author":"Cohn","year":"1999","journal-title":"Transplantation"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0150","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0272-6386(12)80128-4","article-title":"Primary focal segmental glomerulosclerosis: Clinical course and response to therapy","volume":"23","author":"Korbet","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0155","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/0002-9343(87)90155-0","article-title":"Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Regional Glomerulonephritis Registry Study","volume":"82","author":"Pei","year":"1987","journal-title":"Am J Med"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0160","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/j.1552-4604.1998.tb04424.x","article-title":"Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft function","volume":"38","author":"Shaw","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"10.1046\/j.1523-1755.2002.00214.x_bb0165","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0272-6386(99)70358-6","article-title":"Mycophenolate mofetil in cadaveric renal transplantation","volume":"34","author":"U.S. Renal Transplant Mycophenolate Mofetil Study Group","year":"1999","journal-title":"Am J Kidney Dis"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381548319X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381548319X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T02:46:51Z","timestamp":1621133211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S008525381548319X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["S008525381548319X"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00214.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}